# Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

> **NCT00788307** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Ad5-CMV-NIS
- **DRUG:** liothyronine sodium
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** laboratory biomarker analysis
- **RADIATION:** iodine I 131

## Key facts

- **NCT ID:** NCT00788307
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11-03
- **Primary completion:** 2018-02-07
- **Final completion:** 2018-02-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** closed early due to poor accrual
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788307, "Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00788307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*